Gene · 2041
Papers3,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| VEGF-A-related genetic variants protect against Alzheimer's disease. | Aging (Albany NY) | 2022 | 35347084 | PubTator, text mining | PubMed |
| NADPH oxidase 4 signaling in a ventilator-induced lung injury mouse model. | Respir Res | 2022 | 35346198 | PubTator, text mining | PubMed |
| Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-d], [3,2-d], [3,4-d] and [4,3-d]pyrimidine Derivatives. | Pharmaceuticals (Basel) | 2022 | 35337149 | PubTator, text mining | PubMed |
| Gene Expression Profiling and Protein Analysis Reveal Suppression of the C-Myc Oncogene and Inhibition JAK/STAT and PI3K/AKT/mTOR Signaling by Thymoquinone in Acute Myeloid Leukemia Cells. | Pharmaceuticals (Basel) | 2022 | 35337104 | PubTator, text mining | PubMed |
| Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms. | Viruses | 2022 | 35336948 | PubTator, text mining | PubMed |
| Rostrocaudal patterning and neural crest differentiation of human pre-neural spinal cord progenitors in vitro. | Stem Cell Reports | 2022 | 35334218 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management. | Int J Mol Sci | 2022 | 35328669 | PubTator, text mining | PubMed |
| Differential Transcriptome Profiling Unveils Novel Deregulated Gene Signatures Involved in Pathogenesis of Alzheimer's Disease. | Biomedicines | 2022 | 35327413 | PubTator, text mining | PubMed |
| An shRNA kinase screen identifies regulators of UHRF1 stability and activity in mouse embryonic stem cells. | Epigenetics | 2022 | 35324392 | PubTator, text mining | PubMed |
| The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer. | Front Cell Dev Biol | 2022 | 35309935 | PubTator, text mining | PubMed |
| Roles of Eph-Ephrin Signaling in the Eye Lens Cataractogenesis, Biomechanics, and Homeostasis. | Front Cell Dev Biol | 2022 | 35295853 | PubTator, text mining | PubMed |
| Tracheal separation is driven by NKX2-1-mediated repression of Efnb2 and regulation of endodermal cell sorting. | Cell Rep | 2022 | 35294885 | PubTator, text mining | PubMed |
| Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases. | Cell Rep | 2022 | 35294868 | PubTator, text mining | PubMed |
| DNA Methylation Markers and Prediction Model for Depression and Their Contribution for Breast Cancer Risk. | Front Mol Neurosci | 2022 | 35283726 | PubTator, text mining | PubMed |
| Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer. | J Biol Chem | 2022 | 35278434 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Colorectal Cancer. | Int J Mol Sci | 2022 | 35269901 | PubTator, text mining | PubMed |
| Better Agreement of Human Transcriptomic and Proteomic Cancer Expression Data at the Molecular Pathway Activation Level. | Int J Mol Sci | 2022 | 35269755 | PubTator, text mining | PubMed |
| CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future. | Front Immunol | 2022 | 35265074 | PubTator, text mining | PubMed |
| The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility. | Sci Rep | 2022 | 35264657 | PubTator, text mining | PubMed |
| ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation. | Cell Mol Biol Lett | 2022 | 35260073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2041/papers?page=28